You are here: Industry Insights > ANSM

News List

PEP-Therapy, Institut Curie Granted Approval for PEP-010 Trial for Advanced Solid Tumors americanpharmaceuticalreview
March 23, 2021
PEP-Therapy and Institut Curie have been granted approval from the French National Agency for Medicines and Health Products (ANSM) to proceed with the first-in-human clinical trial of PEP-Therapy's lead drug candidate, PEP-010.
Lupin’s Mandideep facility inspection completed by ANSM expresspharma
August 07, 2019
Drug firm Lupin on Tuesday said inspection of a unit of its Mandideep facility in Madhya Pradesh by the French National Agency for Medicines and Health Products Safety (ANSM) has been completed with no major observations.
Alcohol-related Disorders: Ethypharm Is Granted Marketing Authorisation for Its Drug Baclocur firstwordpharma
October 29, 2018
Alcohol-related Disorders: Ethypharm Is Granted Marketing Authorisation for Its Drug Baclocur
Aptar Pharma’s multidose dispenser approved by ANSM financialexpress
June 29, 2018
Aptar Pharma’s innovative, preservative-free multidose ophthalmic squeeze dispenser is the approved delivery device for Bausch+Lomb’s Levofree Multidose in France. This marks the first approval by the French National Agency for Medicines and Health Produc
ANSM grants authorisation for phase I/II clinical study for retinitis pigmentosa europeanpharmaceuticalreview
October 12, 2017
The French National Agency for Medicines and Health Products Safety is set to launch a Phase I/II clinical trial for HORA-PDE6B, in the treatment of a retinitis pigmentosa…